Synthesis and In Vitro Cytotoxic Activity of Novel Chalcone-Like Agents

Document Type: Original Article

Authors

1 Department of Chemistry, Central Tehran-Branch, Islamic Azad University, Tehran, Iran

2 Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran

3 Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

4 Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

5 Institute of Biochemistry and Biophysics, University of Tehran, Tehran, IranDepartment of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

6 Department of Chemistry, Tabriz Branch, Islamic Azad University, Tabriz, Iran

Abstract

 




Objective(s):
Chalcones and their rigid analogues represent an important class of small molecules having anticancer activities. Therefore, in this study the synthesis and cytotoxic activity of new 3-benzylidenchroman-4-ones were described as rigid chalcone analogues.
 
Materials and Methods:
The reaction of resorcinol with 3-chloropropionic acid in the presence of CF3SO3H was afforded corresponding propiophenone. It was cyclized using 2M NaOH to give 7-hydroxy-4-chromanone. O-Alkylation of 7-hydroxy-4-chromanone with alkyl iodide in the presence of K2CO3 gave 7-alkoxychroman-4-one. Finally, condensation of chroman-4-one derivatives with different aldehydes afforded target compounds in good yields. The newly synthesized compounds were tested in vitro against different human cancer cell lines including K562 (human erythroleukemia), MDA-MB-231 (human breast cancer), and SK-N-MC (human neuroblastoma) cells. The cell viability was evaluated using MTT colorimetric assay.
Results:
Most of the compounds showed good inhibitory activity against cancer cells. Among them, compound 4a containing 7-hydroxy group on chromanone ring and 3-bromo-4-hydroxy-5-methoxy substitution pattern on benzylidene moiety was the most potent compound with IC50 values ≤ 3.86 μg/ml. It was 6-17 times more potent than etoposide against tested cell lines.
Conclusion:
We described synthesis and cytotoxic activity of poly-functionalized 3-benzylidenechroman-4-ones as new chalcone-like agents. These compounds can be considered as conformationally constrained congeners of chalcones to tolerate the poly-functionalization on the core structures for further optimization.

Keywords


1. Harrison M, Holen K, Liu G. Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins. Clin Adv Hematol Oncol 2009; 7:54–64.

2. Eckhardt S: Recent progress in the development of anticancer agents. Curr Med Chem-Anti-Cancer Agents 2002; 2:419–439.

3. Sierra JR, Cepero V, Giordano S. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy. Mol Cancer 2010; 9:75–88.

4. Hinnen P, Eskens FA. Vascular disrupting agents in clinical development. Br J Cancer 2007; 96:1159–1165.

5. Dimmock JR, Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Curr Med Chem 1999; 6:1125–1149.

6. Shi H-B, Zhang S-J, Ge Q-F, Guo D-W, Cai C-M, Hu W-X. Synthesis and anticancer evaluation of thiazolyl–chalcones. Bioorg Med Chem Lett 2010; 20:6555–6559.

7. Firoozpour L, Edraki N, Nakhjiri M, Emami S, Safavi M, Ardestani SK,

et al. Cytotoxic activity evaluation and QSAR study of chromene-based chalcones. Arch Pharm Res 2012; 35:2117-2125.

8. Go ML

, Wu X, Liu X. Chalcones: An update on cytotoxic and chemoprotective properties. Curr Med Chem 2005; 12:483499.

9. Aryapour H, Riazi GH, Foroumadi A, Ahmadian S, Shafiee A, Karima O,

et al. Biological evaluation of synthetic analogues of curcumin: chloro-substituted-2'-hydroxychalcones as potential inhibitors of tubulin polimerization and cell proliferation. Med Chem Res 2011; 20:503–510.

10. Shan Y

, Zhang J, Z Liu, M Wang, Dong Y. Developments of combretastatin A-4 derivatives as anticancer agents. Curr Med Chem 2011; 18:523538.

11. Dimmock JR

, Kandepu NM, Zanarali AJ, Kowalchuk TP, Motagabahalli N, Quail JW, et al. Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones. J Med Chem 1999; 42:13581366. Cytotoxic Activity of Novel Chalcone-like agents Letafat et al

Iran J Basic Med Sci, Vol. 16, No. 11, Nov 2013

 

1162

12. Dimmock JR

, Zello GA, Oloo EO, Quail JW, Kraatz H-B, Perjési P, et al. Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography. J Med Chem 2002; 45:31033111.

13. Perjési P

, Das U, De Clercq E, Balzarini J, Kawase M, Sakagami H, et al. Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells. Eur J Med Chem 2008; 43:839845.

14. Rafinejad A, Fallah-Tafti A, Tiwari R, Nasrolahi Shirazi A, Mandal D, Shafiee A,

et al. 4-Aryl-4H-naphthopyrans derivatives: One-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities. Daru J Pharm Sci 2012; 20:100.

15. Bazl R, Ganjali M, Saboury A, Foroumadi A, Nourozi P, Amanlou M. A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and

in vitro study. Daru J Pharm Sci 2012; 20:64.

16. Vosooghi M, Divsalar K, Shamsa H, Kheirollahi A, Safavi M, Ardestani SK,

et al. Synthesis and in vitro cytotoxic activity evaluation of 16-(substituted benzylidene) derivatives of dehydroepiandrosterone. Daru J Pharm Sci 2013; 21:34.

17. Foroumadi A, Samzadeh-Kermani A, Emami S, Dehghan GH, Sorkhi M, Arabsorkhi F,

et al. Synthesis and antioxidant properties of substituted 3-benzylidene-7-alkoxychroman-4-ones. Bioorg Med Chem Lett 2007; 17:6764–6769.

18. a) Nakhjiri M, Safavi M, Alipour E, Emami S, Atash AF, Jafari-Zavareh M,

et al. Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study. Eur J Med Chem 2012; 50:113–123. b) Safavi M, Esmati N, Ardestani SK, Emami S, Ajdari S, Davoodi J, et al. Halogenated flavanones as potential apoptosis-inducing agents: synthesis and biological activity evaluation. Eur J Med Chem 2012; 58:573-580.

19. Noushini S, Emami S, Safavi M, Kabudanian Ardestani S, Gohari AR, Shafiee A,

et al. Synthesis and cytotoxic properties of novel (E)-3-benzylidene-7-methoxychroman-4-one derivatives. Daru J Pharm Sci 2013; 21:31.

20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55–63.